Clinical Trials on 2- HIV Infection in Australia

Total 2416 results

Abbott

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Influenza

Australia
Kepler University Hospital

Completed

Low-grade Infections of the Intervertebral Discs

Disc Degeneration

Austria
Emergent BioSolutions

Completed

Universal Influenza A Vaccine in Healthy Adults (EBS-UFV-001)

Human Influenza

Australia
Medical University Innsbruck
Ruth Kröss, MD EDAIC; Glodny Bernhard, MD PD Assoc. Prof.; Laura Trefzer, Cand... and other collaborators

Completed

Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access

Emergencies | Bone Infection | Infusion Site Injury

Austria
Astellas Pharma Europe Ltd.
Cubist Pharmaceuticals LLC

Terminated

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

Clostridium Difficile

Spain, France, Germany, Greece, Denmark, Austria, Poland
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus

Hepatitis B

United States, Australia, Canada, New Zealand
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
Royal Brisbane and Women's Hospital
The University of Queensland

Completed

An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT (CT-PK)

Gram-Negative Bacterial Infections

Australia
ViiV Healthcare
GlaxoSmithKline

Completed

Dolutegravir Expanded Access Study (DEAP)

HIV Infections | Infection, Human Immunodeficiency Virus

France, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
Medical University of Graz

Completed

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids (HUCKEPACK2)

Type 2 Diabetes

Austria
Themis Bioscience GmbH

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

Chikungunya Virus Infection

Austria, Germany
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B (PIPET B)

Pandemic Influenza

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza (PIPET C)

Pandemic Influenza

Australia
Bayside Health

Completed

Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans

Obesity | Insulin Resistance | Type 2 Diabetes

Australia
The University of Queensland
Shionogi

Completed

RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI (GAMECHANGER)

Bloodstream Infections

Taiwan, Thailand, Singapore, Australia, Malaysia, Turkey
DiObex

Terminated

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Type 2 Diabetes

Australia, United States, New Zealand
Baker Heart Research Institute

Unknown

The Effects of Weight Loss on Neuroadrenergic Function

Obesity | Metabolic Syndrome | Type 2 Diabetes

Australia
Medical University of Graz

Completed

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines (TNF4)

Obesity | Type 2 Diabetes Mellitus

Austria
Macfarlane Burnet Institute for Medical Research...
Department of Health and Human Services

Recruiting

Link Hepatitis C Notifications to Treatment in Tasmania

Hepatitis C

Australia
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection

Hepatitis C Virus Infection

France, Austria, Germany, Italy
Lumen Bioscience, Inc.

Completed

A Study to Determine the Tolerability of Intranasal LMN-301

COVID-19

Australia
Menzies School of Health Research
World Health Organization; Universidade da Paz

Completed

Food Incentives for TB Treatment Compliance in East Timor (FITTCET)

Tuberculosis

Australia
Kirby Institute
The University of New South Wales

Completed

Australian Trial in Acute Hepatitis C Recall Study (ATAHC Recall)

Acute Hepatitis C

Australia
Bayside Health
Monash University; Western Sydney Local Health District; Eastern Health; Fremantle... and other collaborators

Unknown

fungalAi for Fungal Surveillance & Antifungal Stewardship (fungalAi)

Fungal Infections

Australia
Bristol-Myers Squibb

Completed

Safety Study of BMS-816336 in Healthy Male Subjects

Dyslipidemia | Diabetes Mellitus, Non-Insulin-Dependent

Australia
Hoffmann-La Roche
Trimeris

Completed

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

HIV Infections

Switzerland, Spain, United Kingdom, Germany, Belgium, Australia, Sweden, Italy, Netherlands
Moat Biotechnology Corporation
Moat Biotechnology Corporation

Recruiting

A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers

Covid19

Australia
National Institute of Integrative Medicine, Australia

Unknown

International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

COVID19

Australia
Kirby Institute
National Health and Medical Research Council, Australia

Withdrawn

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza (PIPET A)

Pandemic Influenza

Australia
Tibotec Pharmaceuticals, Ireland

Completed

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

HIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1

United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Healthy Volunteers | Respiratory Syncytial Virus Infection

Australia, Dominican Republic, Honduras
Macfarlane Burnet Institute for Medical Research...
The University of Queensland; Cairns Hinterland Health Hospital and Health...

Completed

Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

Hepatitis C

Australia
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Healthy Volunteers | Respiratory Syncytial Virus Infection | Metapneumovirus Infection

Australia, United States
Murdoch Childrens Research Institute
Monash University; St Vincent's Hospital Melbourne; University of Melbourne; The... and other collaborators

Recruiting

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children (INHERIT)

COVID-19

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Withdrawn

COVID-19 Fourth Dose Study in Australia

COVID-19

Australia
Murdoch Childrens Research Institute
Coalition for Epidemic Preparedness Innovations; The Peter Doherty Institute...

Active, not recruiting

COVID-19 Booster Study in Healthy Adults in Australia

COVID-19

Australia
Symvivo Corporation

Completed

Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19

COVID-19

Australia
Landeskrankenanstalten-Betriebsgesellschaft
European Commission

Completed

Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus (RenewingHealth)

Diabetes Mellitus Type 2

Austria
Gilead Sciences

Completed

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

HIV Infections | HIV

United States, Netherlands, Spain, Mexico, France, Thailand, Australia, United Kingdom, Dominican Republic
The University of Queensland
Syneos Health; Coalition for Epidemic Preparedness Innovations

Completed

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Covid19 | SARS-CoV2

Australia
BeiGene

Completed

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Covid19

Australia
Clifford Craig Medical Research Trust
Johns Hopkins Bloomberg School of Public Health; Monash University; University... and other collaborators

Unknown

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Heterologous Effects of Vaccines

Australia
University of Melbourne

Completed

Effects of a Weight Loss Program in People With Hip Osteoarthritis (ECHO)

Hip Osteoarthritis | Overweight and Obesity

Australia
ViiV Healthcare
GlaxoSmithKline; PPD

Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

HIV Infections | Infection, Human Immunodeficiency Virus

Taiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
Invivyd, Inc.
Novotech (Australia) Pty Limited

Completed

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participants

COVID-19

Australia
Telethon Kids Institute

Withdrawn

Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Bronchiolitis

Australia
Arixa Pharmaceuticals

Unknown

A Single Ascending Dose Study of AV-006 in Healthy Subjects

Bacterial Infections

Australia
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults (SAILING)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
ViiV Healthcare
GlaxoSmithKline

Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
BeiGene

Recruiting

Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

Locally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2

Australia, Spain, France, Italy, Korea, Republic of, Poland

Clinical Trials on 2- HIV Infection in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations